Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Assets Average (2021 - 2023)

Terns Pharmaceuticals' Assets Average history spans 3 years, with the latest figure at $280.7 million for Q3 2023.

  • For Q3 2023, Assets Average rose 66.36% year-over-year to $280.7 million; the TTM value through Sep 2023 reached $280.7 million, up 66.36%, while the annual FY2022 figure was $227.5 million, 74.79% up from the prior year.
  • Assets Average reached $280.7 million in Q3 2023 per TERN's latest filing, down from $295.5 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $295.5 million in Q2 2023 to a low of $145.8 million in Q1 2021.
  • Average Assets Average over 3 years is $208.1 million, with a median of $183.9 million recorded in 2021.
  • Peak YoY movement for Assets Average: decreased 22.14% in 2022, then soared 96.0% in 2023.
  • A 3-year view of Assets Average shows it stood at $174.0 million in 2021, then surged by 37.84% to $239.8 million in 2022, then increased by 17.05% to $280.7 million in 2023.
  • Per Business Quant, the three most recent readings for TERN's Assets Average are $280.7 million (Q3 2023), $295.5 million (Q2 2023), and $294.2 million (Q1 2023).